Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney.

Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD.

Kidney Int. 2010 May;77(9):771-80. doi: 10.1038/ki.2010.12. Epub 2010 Feb 17.

2.

Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Liu Z, Gong R.

Am J Kidney Dis. 2015 Nov;66(5):846-56. doi: 10.1053/j.ajkd.2015.06.026. Epub 2015 Aug 10. Review.

3.

Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.

Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR.

J Surg Res. 2008 Dec;150(2):304-30. doi: 10.1016/j.jss.2007.12.747. Epub 2008 Jan 22. Review.

PMID:
19040966
4.

T lymphocytes and acute kidney injury: update.

Martina MN, Noel S, Bandapalle S, Hamad AR, Rabb H.

Nephron Clin Pract. 2014;127(1-4):51-5. doi: 10.1159/000363719. Epub 2014 Sep 24. Review.

5.

Remote Ischemic Conditioning and Renal Protection.

Giannopoulos G, Vrachatis DA, Panagopoulou V, Vavuranakis M, Cleman MW, Deftereos S.

J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):321-329. doi: 10.1177/1074248417702480. Epub 2017 Apr 26. Review.

PMID:
28443376
6.

[The role of pharmacological preconditioning in renal ischemic and reperfusion injury].

Kostina DA, Pokrovskaya TG, Olefir YV, Yavorskii AN, Elagin VV.

Urologiia. 2017 Oct;(5):139-144. Review. Russian.

PMID:
29135158
7.

Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Camara-Lemarroy CR.

World J Gastroenterol. 2014 Apr 7;20(13):3572-81. doi: 10.3748/wjg.v20.i13.3572. Review.

8.

Regulatory T cells in AKI.

Kinsey GR, Sharma R, Okusa MD.

J Am Soc Nephrol. 2013 Nov;24(11):1720-6. doi: 10.1681/ASN.2013050502. Epub 2013 Oct 17. Review.

9.

Ischemic Conditioning in Kidney Transplantation.

Veighey K, MacAllister R.

J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):330-336. doi: 10.1177/1074248417702893. Epub 2017 Apr 11. Review.

PMID:
28395520
10.

Immunologic research in kidney ischemia/reperfusion injury at Johns Hopkins University.

Ko GJ, Zakaria A, Womer KL, Rabb H.

Immunol Res. 2010 Jul;47(1-3):78-85. doi: 10.1007/s12026-009-8140-7. Review.

PMID:
20082154
11.

The innate immune response in ischemic acute kidney injury.

Jang HR, Rabb H.

Clin Immunol. 2009 Jan;130(1):41-50. doi: 10.1016/j.clim.2008.08.016. Epub 2008 Oct 14. Review.

12.

The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.

McCafferty K, Forbes S, Thiemermann C, Yaqoob MM.

Dis Model Mech. 2014 Dec;7(12):1321-33. doi: 10.1242/dmm.016741. Review.

13.

Macrophage-mediated injury and repair after ischemic kidney injury.

Huen SC, Cantley LG.

Pediatr Nephrol. 2015 Feb;30(2):199-209. doi: 10.1007/s00467-013-2726-y. Epub 2014 Jan 19. Review.

14.

Macrophages, dendritic cells, and kidney ischemia-reperfusion injury.

Li L, Okusa MD.

Semin Nephrol. 2010 May;30(3):268-77. doi: 10.1016/j.semnephrol.2010.03.005. Review.

15.

Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Bajwa A, Kinsey GR, Okusa MD.

Curr Drug Targets. 2009 Dec;10(12):1196-204. Review.

16.

Pharmacology of Ischemia-Reperfusion. Translational Research Considerations.

Prieto-Moure B, Lloris-Carsí JM, Barrios-Pitarque C, Toledo-Pereyra LH, Lajara-Romance JM, Berda-Antolí M, Lloris-Cejalvo JM, Cejalvo-Lapeña D.

J Invest Surg. 2016 Aug;29(4):234-49. doi: 10.3109/08941939.2015.1119219. Epub 2016 May 23. Review.

PMID:
27216877
17.

Preconditioning: from experimental findings to novel therapies in acute kidney injury.

Shihab FS.

Minerva Urol Nefrol. 2009 Sep;61(3):143-57. Review.

PMID:
19773719
18.

Innate Immune Response in Kidney Ischemia/Reperfusion Injury: Potential Target for Therapy.

Kezić A, Stajic N, Thaiss F.

J Immunol Res. 2017;2017:6305439. doi: 10.1155/2017/6305439. Epub 2017 Jun 6. Review.

19.

Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection.

Gesuete R, Stevens SL, Stenzel-Poore MP.

Acta Neurochir Suppl. 2016;121:39-44. doi: 10.1007/978-3-319-18497-5_7. Review.

20.

Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks.

Morris CF, Tahir M, Arshid S, Castro MS, Fontes W.

J Immunol Res. 2015;2015:697193. doi: 10.1155/2015/697193. Epub 2015 Dec 6. Review.

Supplemental Content

Support Center